Overview
ECG-AI software-as-a-medical-device algorithms analyzing standard 12-lead ECG waveforms to detect low ejection fraction, pulmonary hypertension, cardiac amyloidosis, and additional cardiovascular conditions in development.
Product and company
Anumana — Digital Health is a verified product offering linked to the Brel Digital company profile for Anumana.
Use cases
ECG-AI software-as-a-medical-device algorithms analyzing standard 12-lead ECG waveforms to detect low ejection fraction, pulmonary hypertension, cardiac amyloidosis, and additional cardiovascular conditions in development.
Target customer
Health systems, cardiologists, and primary care networks performing high-volume ECGs who need early detection of heart failure risk, pulmonary hypertension, and amyloidosis without adding separate diagnostic tests at point of care.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.
Sources and references
- Official product / company source: https://anumana.ai/news/anumana-receives-first-and-only-fda-clearance-for-ecg-ai-cardiac-amyloidosis-algorithm-using-a/
- Supporting source: https://www.anumana.ai/about-us/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- ECG-AI software-as-a-medical-device algorithms analyzing standard 12-lead ECG waveforms to detect low ejection fraction, pulmonary hypertension, cardiac amyloidosis, and additional cardiovascular conditions in development.
Extracted from the linked company product description already verified on Brel. No capabilities were invented.